Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human P2Y1 ELISA Kit (AC2923)
Cat.#: ASET-1512
Specifications
Description Human P2Y1 ELISA Kit allows for the in vitro quantitative determination of human P2Y1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1372 Human Bim ELISA Kit (AC2783) Quantitative inquiry ASET-1880 Human SOX9 ELISA Kit (AC3291) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-2211 Mouse Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3622) Quantitative inquiry ASET-1362 Mouse Urocortin ELISA Kit (AC2773) Quantitative inquiry ASET-1445 Mouse ABCA7 ELISA Kit (AC2856) Quantitative inquiry ASET-1704 Human Tyrosine Hydroxylase ELISA Kit (AC3115) Quantitative inquiry ASET-1697 Mouse Neurogranin ELISA Kit (AC3108) Quantitative inquiry ASET-1595 Human SPTBN2 ELISA Kit (AC3006) Quantitative inquiry ASET-1792 Human PGRPS ELISA Kit (AC3203) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket